XML 56 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Increase in revenue adjustment $ 9,000,000.0      
Decrease in net loss $ 9,000,000.0      
Decreased net loss, basic and diluted $ (0.02)      
Revenue recognized $ 31,900,000      
Deferred revenue for customer services 51,300,000 $ 39,300,000    
Total restricted cash 8,600,000 8,400,000    
Advertising costs 54,700,000 11,200,000 $ 62,600,000  
Impairment Losses 0 0 1,300,000  
Deferred Advertising Costs 700,000      
Impairment charges 0 0 0  
Impairment of long-lived assets $ 0 0 33,213,000  
Stock based compensation expense related to restructuring activities     900,000  
Minimum [Member]        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Remaining performance obligation, remaining duration 1 year      
Maximum [Member]        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Remaining performance obligation, remaining duration 2 years      
ESPP [Member]        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Payroll deductions to participate in plan 15.00%      
ESPP [Member] | Class A Common Stock [Member]        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Discount from market price, offering date 85.00%      
Discount from market price, purchase date 85.00%      
Maximum value of shares per employee $ 25,000      
K I T S        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Revenue recognized 21,900,000 24,100,000 38,000,000.0  
Research Services        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Revenue recognized 31,400,000 42,800,000 28,700,000  
Remaining performance obligations 67,800,000 61,900,000    
Deferred revenue for customer services 11,600,000 31,900,000 48,600,000 $ 48,700,000
Contract with customer liability related party amount 9,200,000 30,100,000    
Contract with customer liability revenue recognized related party amount $ 30,100,000 39,900,000    
Consumer services        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Revenue recognized   34,400,000 59,900,000  
Deferred revenue for customer services   $ 39,300,000 $ 38,800,000 $ 74,100,000
Supplier Concentration Risk | Revenue Benchmark [Member] | Microarrays        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Percentage of Revenue 100.00%      
Supplier Concentration Risk | Revenue Benchmark [Member] | K I T S        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Percentage of Revenue 100.00%      
Supplier Concentration Risk | Revenue Benchmark [Member] | Laboratory Services        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Percentage of Revenue 100.00% 100.00% 100.00%  
Other charges [Member] | Additions to restructuring plan [Member]        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Impairment loss     $ 12,600,000